Universe Pharmaceuticals Balance Sheet (2020-2025) | UPC

Balance Sheet Sep2020 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Sep2025
Assets
Current Assets
Cash & Equivalents 0.01B0.01B0.01B5.71B0.01B0.00B0.01B5.29B33.59B
Short-term Investments 0.01B0.01B0.01B0.01B0.00B0.00B1.38B
Cash & Current Investments 0.01B0.02B0.03B5.72B0.03B0.00B0.01B6.66B33.59B
Receivables - Net 10,871.78B0.02B0.02B0.02B0.02B0.01B0.01B13.04B13.03B
Receivables - Other 0.00B0.00B0.39B5.67B2,280.68B
Receivables 10,871.78B0.02B0.02B0.02B0.02B0.40B0.01B18.71B2,293.71B
Raw Materials 0.00B0.00B0.00B0.98B2.49B
Finished Goods 0.00B0.00B0.00B1.14B1.61B
Inventory 1,906.23B0.00B0.00B0.00B0.00B-0.17B0.00B978.20B-1.51B
Current Deferred Tax Assets 0.01B0.01B
Prepaid Assets 0.00B0.00B0.00B0.85B0.18B
Current Assets 23,279.92B0.05B0.05B0.04B0.05B0.03B0.03B51,637.78B53,603.68B
Non-Current Assets
Property, Plant & Equipment (Net) 4,428.06B0.00B0.00B0.00B0.00B0.00B0.00B3,568.05B3,583.55B
Long-Term Investments 735.00B0.00B0.00B0.00B0.00B0.70B0.00B712.49B702.35B
Intangibles 174.78B0.00B0.00B0.00B0.00B0.00B0.00B262.88B296.79B
Goodwill & Intangibles 174.78B0.00B0.00B0.00B0.00B0.00B0.00B262.88B296.79B
Long-Term Deferred Tax 186.54B0.00B0.00B0.00B0.00B-0.95B
Other Non-Current Assets 0.00B0.00B0.00B0.04B
Non-Current Assets 5,524.38B0.02B0.02B0.02B0.02B0.02B0.02B16.32B15.70B
Assets 28.800.07B0.07B0.06B0.07B0.04B0.05B0.00B69.30B
Liabilities
Current Liabilities
Accounts Payables 0.01B0.00B1.64B0.14B-3.13B
Notes Payables 2,646.00B0.00B0.00B0.00B0.00B0.01B0.00B5,856.70B7,149.88B
Payables 2,646.00B0.01B0.00B0.01B0.00B1.65B0.00B5,856.85B7,146.75B
Accumulated Expenses 0.00B0.00B0.05B
Other Accumulated Expenses 0.00B0.00B0.07B1,266.88B-0.71B
Short term Debt 956.49B0.00B0.00B0.00B0.01B0.01B0.01B6,900.58B446.55B
Current Taxes 0.00B0.00B0.00B0.00B1.02B0.64B
Current Deferred Revenue 40.71B
Total Current Liabilities 8,001.39B0.01B0.01B0.01B0.02B0.01B0.02B20,312.97B13,173.93B
Non-Current Liabilities
Non-Current Debt 0.00B2,137.48B
Other Non-Current Liabilities 2,439.53B0.00B0.00B0.00B0.00B0.00B0.00B2,439.53B2,439.53B
Total Non-Current Liabilities -2439.56B0.02B-0.00B-35.27B-0.00B0.01B0.02B2,137.48B-2426.36B
Total Liabilities -0.02B0.02B-35.27B0.01B0.02B22,450.45B13.17B
Shareholder's Equity
Total Debt 956.49B0.00B0.00B0.00B0.01B0.01B0.01B9,038.07B446.55B
Common Equity 0.02B0.05B35.33B27.97B45.50B56.13B
Shareholder's Equity 0.02B0.05B0.06B35.33B0.05B27.97B0.03B45,502.94B56,129.51B
Liabilities and Shareholders Equity 28.800.07B0.07B0.06B0.07B0.04B0.05B0.00B69.30B
Retained Earnings 13,738.98B0.03B0.03B0.02B0.02B-0.00B-0.00B-10171.57B-13843.62B
Preferred Shares 3,679.00B29,279.16B0.03B0.03B0.03B0.03B53,864.72B63,009.57B